(Q53264343)

English

Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.

scientific article published on 10 January 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

gynecologic oncology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Richard P McQuellon

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

Howard T Thaler

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

David Cella

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

David H Moore

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

language of work or name

0 references

publication date

10 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

101

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

296-304

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Prospective assessment of quality of life of female cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Which dimensions of health-related quality of life are altered in patients attending the different gynecologic oncology health care settings?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Remission of metastatic cervical adenocarcinoma with weekly paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Using data from studies of health-related quality of life to describe clinical issues examples from a longitudinal study of patients with advanced stages of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.039

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.10.039

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16376417

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53264343&oldid=1584450693"